Upcoming changes to L&I's Outpatient Drug Formulary

Washington State Department of Labor & Industries sent this bulletin at 11/20/2024 02:51 PM PST

Having trouble viewing this email? View it as a Web page.
washington state department of labor and industries - claims and insurance

Self-Insurance

Upcoming changes to L&I's Outpatient Drug Formulary

The Washington State Department of Labor & Industries announces changes to our Outpatient Drug Formulary effective January 1, 2025. The changes are available for review in our online Outpatient Drug Formulary PDF document.

Summary of changes

  • Added the following new drug classes:

Drug class code

Drug class description

Drugs in class

H5A

Neurotonics/Cerebrovascular Accident Agents

gamma-aminobutyric acid

H82

Antipsychotics, Muscarinic Agonist/antagonist Combinations

xanomeline/trospium (Cobenfy)

V4J

Interleukin-31 Receptor Alpha Antagonist, Monoclonal Antibody

nemolizumab (Nemluvio)

ZAH

Heat Shock Protein Modulating Agents

arimoclomol (Miplyffa)